Prometheus Life Technologies Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $50K

  • Investors
  • 8

Prometheus Life Technologies General Information

Description

Operator of a space biology company intended to develop and establish the production of human tissue organoids in space. The company's mission is to help millions by harnessing the space environment and space technologies to develop better therapies, enabling patients to get improved drug development and testing and regenerative medicine.

Contact Information

Website
www.plt.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Switzerland Innovation Park
  • Wangenstrasse 68
  • 8600 Dübendorf
  • Switzerland
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Switzerland Innovation Park
  • Wangenstrasse 68
  • 8600 Dübendorf
  • Switzerland

Prometheus Life Technologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prometheus Life Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 18-Dec-2024 $50K Completed Generating Revenue
6. Accelerator/Incubator 04-Dec-2024 Completed Generating Revenue
5. Early Stage VC Completed Generating Revenue
4. Accelerator/Incubator 18-Jan-2023 Completed Generating Revenue
3. Grant 08-Dec-2022 Completed Generating Revenue
2. Joint Venture Completed Generating Revenue
1. University Spin-Out 01-Jan-2022 Completed Generating Revenue
To view Prometheus Life Technologies’s complete valuation and funding history, request access »

Prometheus Life Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prometheus Life Technologies Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Humans In Space Other
Business in Space Growth Network Accelerator/Incubator
ESA BIC Switzerland Accelerator/Incubator Minority
Blue Origin Enterprises VC-Backed Company
University of Zürich University
You’re viewing 5 of 8 investors. Get the full list »

Prometheus Life Technologies FAQs

  • When was Prometheus Life Technologies founded?

    Prometheus Life Technologies was founded in 2022.

  • Where is Prometheus Life Technologies headquartered?

    Prometheus Life Technologies is headquartered in Dübendorf, Switzerland.

  • What is the size of Prometheus Life Technologies?

    Prometheus Life Technologies has 4 total employees.

  • What industry is Prometheus Life Technologies in?

    Prometheus Life Technologies’s primary industry is Biotechnology.

  • Is Prometheus Life Technologies a private or public company?

    Prometheus Life Technologies is a Private company.

  • What is Prometheus Life Technologies’s current revenue?

    The current revenue for Prometheus Life Technologies is .

  • How much funding has Prometheus Life Technologies raised over time?

    Prometheus Life Technologies has raised $214K.

  • Who are Prometheus Life Technologies’s investors?

    Humans In Space, Business in Space Growth Network, ESA BIC Switzerland, Blue Origin Enterprises, and University of Zürich are 5 of 8 investors who have invested in Prometheus Life Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process